Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Matrix metallopeptidase 9 (MMP9) is a zinc-dependent endopeptidase belonging to the matrix metalloproteinase family. It plays a crucial role in the degradation of extracellular matrix components, influencing processes such as tissue remodeling, inflammation, angiogenesis, and tumor metastasis. MMP9 is synthesized as an inactive zymogen and activated by proteolytic cleavage. Elevated MMP9 levels are associated with various diseases, making it a potential therapeutic target and biomarker.
Inhibition of MMP9 enzymatic activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Matrix metallopeptidase 9 (MMP9).